Browse every story filed under this topic, curated from trusted publishers around the world.
Merck’s HIV drug Idvynso could become a drug choice for patients who need to switch from Gilead Sciences’ Biktarvy for safety or tolerability reasons. The Merck combination drug pairs two molecules that bring different mechanisms of …
Read full story →You've seen all articles for #sciences.
Check back
soon
for new stories.